Fayad Al-Haimus: Key Themes from the New 2026 AHA/ACC Guideline for Acute PE
Fayad Al-Haimus, Adult Thrombosis Fellow at McMaster University, shared a post on LinkedIn about a recent article by Mark Creager et al. published in AHA/ASA Journals:
“New 2026 AHA/ACC Guideline for Acute Pulmonary Embolism
A major, multidisciplinary update on how we evaluate, risk stratify, and manage PE has just been published in Circulation Journal.
After going through the document, a few themes stand out that will meaningfully impact day-to-day practice:
- A New PE Classification (A-E)
The guideline introduces an AHA/ACC Acute PE Clinical Category system (A-E), moving beyond the traditional ‘massive vs submassive’ framework. This aligns PE care with modern shock and heart failure paradigms, and importantly recognizes entities like ‘shock without hypotension’. - Smarter, More Efficient Diagnostics
Strong emphasis on Age-adjusted D-dimer and YEARS algorithm to safely avoid unnecessary imaging. - Anticoagulation Remains the Foundation
Clear recommendation: LMWH preferred over UFH when parenteral therapy is needed (unless instability or procedures expected). - PERT Becomes Central to Care
Strong recommendation for Pulmonary Embolism Response Teams (PERT). PERT activation is now recommended for Categories C-E. Think CODE PE similar to CODE STEMI. - A Paradigm Shift in Advanced Therapy
An important shift in the 2026 AHA/ACC PE guideline is how we think about advanced therapy. It’s no longer simply: ‘Remove the clot’. It’s: Preserve and recover RV function
For those of us in Emergency Medicine and Thrombosis, this will shape how we triage, treat, and follow PE patients moving forward.”
Title: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Authors: Mark Creager, Geoffrey Barnes, Jay Giri, Debabrata Mukherjee, William Jones, Allison Burnett, Teresa Carman, Ana Casanegra, Lana Castellucci, Sherrell Clark, Mary Cushman, Kerstin de Wit, Jennifer Eaves, Margaret Fang, Joshua Goldberg, Stanislav Henkin, Hillary Johnston-Cox, Sabeeda Kadavath, Daniella Kadian-Dodov, William Keeling, Andrew Klein, Jun Li, Michael McDaniel, Lisa Moores, Gregory Piazza, Karen Prenger, Steven Pugliese, Mona Ranade, Rachel Rosovsky, Farla Russo, Eric Secemsky, Akhilesh Sista, Leben Tefera, Ido Weinberg, Lauren Westafer, Michael Young
Read the Full Guideline on AHA/ASA Journals․
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia